Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Rose 45.6% in First Half of 2023

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 10.3 million yuan in the first half of 2023, up 45.6% year-on-year.

Meanwhile, the company posted 728.5 million yuan in revenue, up 5% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 47.5%.